Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-09-10

Clinical Trial Update: Walnut Oral Immunotherapy for Tree Nut Allergy [NA]

View source ↗

Summary

A walnut oral immunotherapy trial for peanut and tree nut allergy has been withdrawn, with no recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Walnut Oral Immunotherapy

Snippet

Sponsor: Jonathan Spergel | Conditions: Peanut Allergy | NA | Status: WITHDRAWN